ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

BENJAMIN COCKCROFT MD

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

8,215Medicare Part D Prescriptions Filled, Including Refills

Rank: 93 out of 1155

$467K Total Retail Price of All Prescriptions

Rank: 59 out of 1155

408 Patients Receiving at Least One Drug in Part D
65%Patients 65 Years and Older
61% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Oregon
Lower avg

Schedule Two
Controlled Substances

18% of this provider’s 408 patients filled at least one prescription for a schedule two drug, compared to an average of 9%.

Schedule Three
Controlled Substances

13% of this provider’s 408 patients filled at least one prescription for a schedule three drug, compared to an average of 13%.

Risky Drugs to Seniors

1% of this provider’s 5,430 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

21% of this provider’s prescriptions were for brand-name drugs, compared to an average of 21%.

Prescription Price

$57 was the average price of a prescription from this provider, compared to $50 among peers.

Prescriptions per Patient

20 is the average number of prescriptions (including refills) per patient, compared to an average of 16.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Oregon
LISINOPRIL 420 278 1 1
LEVOTHYROXINE SODIUM 365 277 2 2
ATORVASTATIN CALCIUM 269 238 3 12
OMEPRAZOLE 221 134 4 5
SIMVASTATIN 220 166 5 3
HYDROCODONE-ACETAMINOPHEN 157 109 S3 6 4
GABAPENTIN 132 65 7 15
CITALOPRAM HBR 127 86 8 19
OXYCODONE HCL 126 79 S2 9 23
METOPROLOL SUCCINATE 126 91 9 17
METFORMIN HCL 117 62 11 7
WARFARIN SODIUM 116 89 12 11
FUROSEMIDE 112 100 13 8
POTASSIUM CHLORIDE 107 95 14 16
AMLODIPINE BESYLATE 104 100 15 6
LOVASTATIN 102 40 16 13
METOPROLOL TARTRATE 100 76 17 14
LOSARTAN POTASSIUM 99 87 18 18
TAMSULOSIN HCL 99 59 18 27
CRESTOR 89 67 20 34
ALENDRONATE SODIUM 89 70 20 25
CARVEDILOL 88 76 22 28
BACLOFEN 82 16 23 102
FLUTICASONE PROPIONATE 76 48 24 37
TRAZODONE HCL 76 52 24 22
CHLORTHALIDONE 74 55 26 79
PRAVASTATIN SODIUM 73 45 27 20
TRIAMTERENE-HCTZ 70 33 28 51
LANTUS 68 35 29 39
RANITIDINE HCL 67 44 30 33
FLUOXETINE HCL 66 49 31 30
NIASPAN 62 0 32 168
FINASTERIDE 61 46 33 104
NAMENDA 57 55 34 67
LIPITOR 56 38 35 138
ADVAIR DISKUS 55 31 36 35
MORPHINE SULFATE ER 54 33 S2 37 36
CYMBALTA 54 41 37 46
ALLOPURINOL 54 38 37 29
SPIRIVA 53 37 40 49
CARBAMAZEPINE 52 27 41 193
HYDROCHLOROTHIAZIDE 51 47 42 9
FENTANYL 50 45 S2 43 64
SERTRALINE HCL 50 34 43 24
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Nov. 14, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.